Literature DB >> 2352440

Immune cells in peripheral lymph and skin of patients with obstructive lymphedema.

W L Olszewski1, A Engeset, A Romaniuk, I Grzelak, A Ziolkowska.   

Abstract

Lymph stasis in the extremities caused by interruption of lymphatics or insufficient lymph propulsion is often complicated by recurrent skin infections. To shed further light on this subject, we studied the phenotypical and functional characteristics of cells in peripheral lymph and skin of patients with obstructive lymphedema. Compared with controls, patients with secondary lymphedema displayed a high concentration of lymphocytes and erythrocytes in peripheral lymph, sometimes increased numbers of B cells, increased density of Langerhans cells in the epidermis and occasionally in the skin papillary layer, strong expression of class II antigens on skin endothelial cells and mononuclear infiltration around blood vessels, and margination of granulocytes in skin blood vessels. Reactivity of lymph cells to mitogens was augmented. Taken together these findings indicate that ongoing chronic inflammatory processes persist in skin with lymph stasis, and, moreover, with impaired lymphocyte and Langerhans cell trafficking from skin to regional lymph nodes and inefficient clearance of foreign antigens, these lymphedematous limbs become susceptible to infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2352440

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  11 in total

Review 1.  Biomarkers of lymphatic function and disease: state of the art and future directions.

Authors:  Kenta Nakamura; Stanley G Rockson
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

2.  Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9.

Authors:  Joseph M Rutkowski; Monica Moya; Jimmy Johannes; Jeremy Goldman; Melody A Swartz
Journal:  Microvasc Res       Date:  2006-07-28       Impact factor: 3.514

3.  3.0 T relaxation time measurements of human lymph nodes in adults with and without lymphatic insufficiency: Implications for magnetic resonance lymphatic imaging.

Authors:  Rachelle Crescenzi; Paula M Donahue; Vaughn G Braxton; Allison O Scott; Helen B Mahany; Sarah K Lants; Manus J Donahue
Journal:  NMR Biomed       Date:  2018-10-12       Impact factor: 4.044

4.  Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema.

Authors:  Jason C Gardenier; Geoffrey E Hespe; Raghu P Kataru; Ira L Savetsky; Jeremy S Torrisi; Gabriela D García Nores; Joseph J Dayan; David Chang; Jamie Zampell; Inés Martínez-Corral; Sagrario Ortega; Babak J Mehrara
Journal:  JCI Insight       Date:  2016-09-22

5.  Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice.

Authors:  Kenta Nakamura; Kavita Radhakrishnan; Yat Man Wong; Stanley G Rockson
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

6.  Inflammatory manifestations of experimental lymphatic insufficiency.

Authors:  Raymond Tabibiazar; Lauren Cheung; Jennifer Han; Jeffrey Swanson; Andreas Beilhack; Andrew An; Soheil S Dadras; Ned Rockson; Smita Joshi; Roger Wagner; Stanley G Rockson
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

Review 7.  Inflammatory Manifestations of Lymphedema.

Authors:  Catherine L Ly; Raghu P Kataru; Babak J Mehrara
Journal:  Int J Mol Sci       Date:  2017-01-17       Impact factor: 5.923

8.  Topical tacrolimus for the treatment of secondary lymphedema.

Authors:  Jason C Gardenier; Raghu P Kataru; Geoffrey E Hespe; Ira L Savetsky; Jeremy S Torrisi; Gabriela D García Nores; Dawit K Jowhar; Matthew D Nitti; Ryan C Schofield; Dean C Carlow; Babak J Mehrara
Journal:  Nat Commun       Date:  2017-02-10       Impact factor: 14.919

9.  Elephantiasis nostras verrucosa.

Authors:  Rafi Fredman; Mayer Tenenhaus
Journal:  Eplasty       Date:  2012-10-12

10.  CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis.

Authors:  Jamie C Zampell; Alan Yan; Sonia Elhadad; Tomer Avraham; Evan Weitman; Babak J Mehrara
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.